位置:首页 > 医药大数据 > 肺癌 > > Trametinib
Trametinib

印度Trametinib

资料发布时间:2018-10-30 14:50:00 最后更新时间: 2021-06-09 15:17:08

【药品简介】 Trametinib是丝裂原活化的细胞外信号调节激酶1(MEK1)和MEK2激酶活性的可逆性抑制剂。MEK蛋白质是细胞外信号相关激酶(ERK)通路的上游调节器,促进细胞增殖。曲美替尼通过抑制MEK可以抑制BRAF V600突变-阳性的癌细胞生长。

【适应症状】 Trametinib,1)单药或与达拉菲尼联和用于BRAF V600E或V600K突变的不可切除或转移性黑色素瘤。 2) 联合达拉菲尼用于BRAF V600E突变-阳性转移性非小细胞性肺癌(NSCLC)。

【 药品别名 】 曲美替尼 Trametinib

印度Trametinib(曲美替尼 Trametinib)价格,正品图片,治疗肺癌药物, 购买Trametinib请到印度药房官方网站进行购买 【印度药房大全目录】

【 市场参考价格 】 ¥10500.00~13500.00

播放/暂停

印度全球药房排名

【印度Trametinib说明书,怎么吃?】

Trametinib(印度)又名曲美替尼 Trametinib,Trametinib适用于1)单药或与达拉菲尼联和用于BRAF V600E或V600K突变的不可切除或转移性黑色素瘤。 2) 联合达拉菲尼用于BRAF V600E突变-阳性转移性非小细胞性肺癌(NSCLC)。 的治疗,Trametinib用法及注意事项,:【用法用量】 1)推荐剂量:2mg/day,口服,每日一次;在相同时间服用,直到疾病进展或出现不可耐受的毒性。 2)至少餐前1小时或餐后2小时服用。 3)剂量调整 首次剂量减低:1.5mg,口服,每日...

Trametinib用法用量】
 
1)推荐剂量:2mg/day,口服,每日一次;在相同时间服用,直到疾病进展或出现不可耐受的毒性。

2)至少餐前1小时或餐后2小时服用。

3)剂量调整

首次剂量减低:1.5mg,口服,每日1次;

第二次剂量减低:1mg,口服,每日1次;
 
随后调整:如不能耐受曲美替尼1mg/day,永久终止使用。

【Trametinib注意事项】
 
1)不推荐用于BRAF抑制剂治疗后进展的黑色素瘤患者。

2)当出现以下达拉菲尼的不良反应时,不推荐调整曲美替尼的剂量:非皮肤性恶性肿瘤和葡萄膜炎。

3)对新原发性皮肤恶性病:无需剂量调整。

Trametinib英文说明书

Trametinib uses

Trametinib is used in the treatment of malignant melanoma.

How trametinib works

Trametinib is a kinase inhibitor. It works by blocking the activity of an abnormal protein that causes abnormal division of cancer cells.

Common side effects of trametinib

Rash, Diarrhea, Swelling of legs, Swelling of hands, Facial swelling。

Trametinib

生物活性

产品描述

Trametinib is an ATP-noncompetitive inhibitor of MEK 1/2 (IC50s: 0.7/0.9 nM). It shows low inhibition for more than 180 kinases, including B-Raf, c-Raf, and MEK5.

靶点活性

MEK1,0.92nM

MEK2,1.8nM

实验溶液

30% PEG400+0.5% Tween80+5% propylene glycol: 15 mg/mL

体外活性

Trametinib (JTP-74057) inhibited the phosphorylation of MBP regardless of the isotype of Raf and MEK (IC50s: 0.92 to 3.4 nM). JTP-74057 demonstrated no inhibition of the kinase activities of c-Raf, B-Raf, ERK1 and ERK2. HT-29 and COLO205 cells, which are known to have a constitutively active B-Raf mutant, were most sensitive to JTP-74057, showing subnanomolar IC50 values. The cell lines bearing a K-Ras mutation showed a wide range of sensitivity to JTP-74057 [1]. Among KRAS mutant cell lines, cell lines with an expression pattern suggestive of epithelial-to-mesenchymal transition were less sensitive to GSK1120212. A proportion of cell lines from certain tissue types not known to carry frequent RAF/RAS mutations also seemed to be sensitive to GSK1120212 [2].

体内活性

Both 0.3 mg/kg and 1 mg/kg of JTP-74057 were effective in inhibiting the HT-29 xenograft growth, and 1 mg/kg of JTP-74057 blocked the tumor increase almost completely. Neither significant changes in body weight nor gross lesions at autopsy were observed in the mice treated with 1 mg/kg of JTP-74057. The phosphorylation of ERK1/2 was completely inhibited in the established tumor tissues by a single oral dose of 1 mg/kg JTP-74057, and both p15INK4b and p27KIP1 protein levels were upregulated after 14 days of treatment with JTP-74057 [1]. JTP-74057 blocked tumor necrosis factor-α and interleukin-6 production from PBMCs. AIA and CIA development were suppressed almost completely by 0.1 mg/kg of JTP-74057. In the CIA, JTP-74057 suppressed collagen-reactive T-cell proliferation ex vivo [3].

激酶实验

Raf-MEK-ERK cascade kinase assay: Non-phosphorylated myelin basic protein (MBP) is coated onto an ELISA plate, and the active form of B-Raf/c-Raf is mixed with unphosphorylated MEK1/MEK2 and ERERK2 in 10 μM ATP and 12.5 mM MgCl2 containing MOPS buffer in the presence of various concentrations of GSK1120212. The phosphorylation of MBP is detected by the anti-phospho-MBP antibody.

细胞实验

Exponentially growing cells are precultured in 96-well tissue culture plates for 24 hours and then exposed to GSK1120212. Cell growth is determined by an in vitro toxicology assay kit, sulforhodamine B based. For apoptosis assay, both floating and adherent cells are collected and fixed with 70% ethanol. After washing with PBS, the cells are suspended in 100 μg/mL RNase and 25 μg/mL propidium iodide (PI) and incubated at 37 °C for 30 minutes in the dark. The DNA content of each single cell is determined using the flow cytometer Cytomics FC500 or Guava EasyCyte plus.(Only for Reference)

细胞系: HT-29, HCT-15, HCT116, COLO205, LS-174T, SW480, SW620, T84, LoVo and COLO320

动物实验

动物模型:FeBALB/c-nu/nu mice inoculated subcutaneously with HT-29 or COLO205 cells

化学信息

分子量

615.39

分子式

C26H23FIN5O4

CAS

871700-17-3

溶解度

DMSO: 21 mg/mL (34.1 mM)

Ethanol: <1 mg/mL

( < 1 mg/ml refers to the product slightly soluble or insoluble )

储存条件

store at -80°C

备注

For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.

配制溶液

  1 mg 5 mg 10 mg
1 mM 1.625 ml 8.125 ml 16.25 ml
5 mM 0.325 ml 1.625 ml 3.25 ml
10 mM 0.162 ml 0.812 ml 1.625 ml
50 mM 0.032 ml 0.162 ml 0.325 ml

参考文献

  • 1. Yamaguchi T, et al. Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo. Int J Oncol, 2011, 39(1), 23-31.
    2. Jing J, et al. Comprehensive predictive biomarker analysis for MEK inhibitor GSK1120212. Mol Cancer Ther. 2012 Mar;11(3):720-9.
    3. Yamaguchi T, et al. Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide. Inflamm Res, 2012, 61(5), 445-454.

注:本站Trametinib(曲美替尼 Trametinib)药品说明,价格,正品图片均来自于官方,Trametinib如何服用请尊医嘱。如需药品请到正规印度药房进行购买
上一篇:色瑞替尼 下一篇:Cabozantinib
Trametinib相关药品
曲美替尼
曲美替尼

【药品特色】曲美替尼治疗伴有BRAF V600E或V600K突变的不可切除或转移性黑色素瘤。曲美替尼和达拉菲尼此两款药为......

Cabozantinib
Cabozantinib

【用法用量】 推荐用量: 1)甲状腺髓样癌:每次140mg,每日一次,轻度及中度肝损伤患者起始剂量为80mg 2)肾癌、......

Trametinib
Trametinib

【用法用量】 1)推荐剂量:2mg/day,口服,每日一次;在相同时间服用,直到疾病进展或出现不可耐受的毒性。 2)至少......

色瑞替尼
色瑞替尼

用法用量】 1)推荐剂量:每次450mg,每天一次,同食物一起服用;长期服用直至疾病出现新的进展或出现不可耐受的毒副作用......

克唑替尼
克唑替尼

【作用机制】 克唑替尼是一个酪氨酸激酶受体抑制剂,抑制间变性淋巴瘤激酶(ALK),肝细胞生长因子(HGFR,c-MET)......

奥希替尼
奥希替尼

作用机制: 奥希替尼是一个EGFR酪氨酸激酶抑制剂,不可逆的与特定的EGFR突变结合,包括T790M,L858R和19号......

阿法替尼
阿法替尼

不良反应: 鳞癌患者(有转移):用于含铂方案化疗肿瘤继续进展者。 作用机制: 高选择性ErbB抑制剂,不可逆的结合酪氨酸......

Erlotinib hydrochloride
Erlotinib hydrochloride

【给药方法】 每天一次,空腹服用(饭前一小时或饭后2小时) 厄洛替尼单药用于非小细胞肺癌的推荐剂量为150mg/日,至少......

吉非替尼
吉非替尼

【作用机制】 吉非替尼是一个酪氨酸激酶抑制剂(TKI),可逆性的抑制特定类型的EGFR突变。EGFR(表皮生长因子受体)......

Trametinib资讯
克唑替尼治疗肺癌有什么副作用?
克唑替尼治疗肺癌有什么副作用?

克唑替尼是一种新型的间变性淋巴瘤激酶(ALK)/间充质上皮生长因子(c-MET)/肝细胞生长因子受体(HGFR)激酶小分......

肺癌患者服用吉非替尼的饮食禁忌
肺癌患者服用吉非替尼的饮食禁忌

吉非替尼作为一种EGFR抑制剂,其作用机制主要是通过抑制EGFR自身磷酸化来阻断传导和抑制肿瘤细胞增殖,从而实现肺癌患者......

曲美替尼的用法用量和不良反应
曲美替尼的用法用量和不良反应

黑色素瘤是最常见的致命性皮肤肿瘤。目前,治疗早期黑色素瘤的首选方法是手术切除和辅助免疫治疗。大多数晚期和转移性黑色素瘤主......

印度厄洛替尼可以治疗肺癌吗
印度厄洛替尼可以治疗肺癌吗

盐酸厄洛替尼片是一种安全性高、副作用小的口服肺癌靶向药物。它不仅能显著延长患者的生存期,而且能显著提高患者的生活质量。但......

服用曲美替尼这些知识你都了解吗?
服用曲美替尼这些知识你都了解吗?

曲美替尼在黑色素瘤治疗领域是众所周知的,为许多病人延长了他们的生命,因为它具有极好的控制癌细胞的能力,这是病人及其家属最......

Trametinib视频
如何预防肺癌?
如何预防肺癌?

预防肺癌的方法为远离五气,大气污染属于政府行为,其他四气可由自己掌控,包括戒烟、绿色装修...

药房目录大全

Pharmacy Catalogue


联系人:
微信:
需要药品:
欢迎更多正规药房加入,如病友有发现销售伪冒药品的网站,也请告知本站,我们将推出黑名单曝光之。联系微信: sun24moon